Better regulation is urgently needed for genetic tests, particularly those marketed directly to the public, argue researchers. In the past 18 months, studies have identified dozens of inherited DNA variations associated with common conditions such as heart attacks, diabetes and asthma. In many cases, these findings provide insight on the cause of the disease, but clinical applications are still mostly unclear.